Literature DB >> 25435137

A computational algorithm to predict shRNA potency.

Simon R V Knott1, Ashley Maceli1, Nicolas Erard1, Kenneth Chang1, Krista Marran1, Xin Zhou1, Assaf Gordon1, Osama El Demerdash1, Elvin Wagenblast1, Sun Kim1, Christof Fellmann1, Gregory J Hannon1,2.   

Abstract

The strength of conclusions drawn from RNAi-based studies is heavily influenced by the quality of tools used to elicit knockdown. Prior studies have developed algorithms to design siRNAs. However, to date, no established method has emerged to identify effective shRNAs, which have lower intracellular abundance than transfected siRNAs and undergo additional processing steps. We recently developed a multiplexed assay for identifying potent shRNAs and used this method to generate ∼250,000 shRNA efficacy data points. Using these data, we developed shERWOOD, an algorithm capable of predicting, for any shRNA, the likelihood that it will elicit potent target knockdown. Combined with additional shRNA design strategies, shERWOOD allows the ab initio identification of potent shRNAs that specifically target the majority of each gene's multiple transcripts. We validated the performance of our shRNA designs using several orthogonal strategies and constructed genome-wide collections of shRNAs for humans and mice based on our approach.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25435137      PMCID: PMC4272634          DOI: 10.1016/j.molcel.2014.10.025

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  65 in total

1.  A cellular function for the RNA-interference enzyme Dicer in the maturation of the let-7 small temporal RNA.

Authors:  G Hutvágner; J McLachlan; A E Pasquinelli; E Bálint; T Tuschl; P D Zamore
Journal:  Science       Date:  2001-07-12       Impact factor: 47.728

2.  Short hairpin RNAs (shRNAs) induce sequence-specific silencing in mammalian cells.

Authors:  Patrick J Paddison; Amy A Caudy; Emily Bernstein; Gregory J Hannon; Douglas S Conklin
Journal:  Genes Dev       Date:  2002-04-15       Impact factor: 11.361

Review 3.  RNA interference.

Authors:  Gregory J Hannon
Journal:  Nature       Date:  2002-07-11       Impact factor: 49.962

4.  Structural basis for 5'-nucleotide base-specific recognition of guide RNA by human AGO2.

Authors:  Filipp Frank; Nahum Sonenberg; Bhushan Nagar
Journal:  Nature       Date:  2010-05-26       Impact factor: 49.962

5.  Dicer functions in RNA interference and in synthesis of small RNA involved in developmental timing in C. elegans.

Authors:  R F Ketting; S E Fischer; E Bernstein; T Sijen; G J Hannon; R H Plasterk
Journal:  Genes Dev       Date:  2001-10-15       Impact factor: 11.361

Review 6.  Induction of stable RNA interference in mammalian cells.

Authors:  Bryan R Cullen
Journal:  Gene Ther       Date:  2006-03       Impact factor: 5.250

7.  Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans.

Authors:  A Fire; S Xu; M K Montgomery; S A Kostas; S E Driver; C C Mello
Journal:  Nature       Date:  1998-02-19       Impact factor: 49.962

8.  Beyond secondary structure: primary-sequence determinants license pri-miRNA hairpins for processing.

Authors:  Vincent C Auyeung; Igor Ulitsky; Sean E McGeary; David P Bartel
Journal:  Cell       Date:  2013-02-14       Impact factor: 41.582

9.  MicroRNAs modulate hematopoietic lineage differentiation.

Authors:  Chang-Zheng Chen; Ling Li; Harvey F Lodish; David P Bartel
Journal:  Science       Date:  2003-12-04       Impact factor: 47.728

10.  Structure of yeast Argonaute with guide RNA.

Authors:  Kotaro Nakanishi; David E Weinberg; David P Bartel; Dinshaw J Patel
Journal:  Nature       Date:  2012-06-20       Impact factor: 49.962

View more
  51 in total

Review 1.  In vivo RNAi screens: concepts and applications.

Authors:  Shane Crotty; Matthew E Pipkin
Journal:  Trends Immunol       Date:  2015-04-27       Impact factor: 16.687

2.  CK1α and IRF4 are essential and independent effectors of immunomodulatory drugs in primary effusion lymphoma.

Authors:  Ajinkya Patil; Mark Manzano; Eva Gottwein
Journal:  Blood       Date:  2018-06-28       Impact factor: 22.113

3.  Viral delivery of shRNA to amygdala neurons leads to neurotoxicity and deficits in Pavlovian fear conditioning.

Authors:  Christopher A de Solis; Roopashri Holehonnur; Anwesha Banerjee; Jonathan A Luong; Srihari K Lella; Anthony Ho; Bahram Pahlavan; Jonathan E Ploski
Journal:  Neurobiol Learn Mem       Date:  2015-07-13       Impact factor: 2.877

4.  Neutrophil extracellular traps produced during inflammation awaken dormant cancer cells in mice.

Authors:  Jean Albrengues; Mario A Shields; David Ng; Chun Gwon Park; Alexandra Ambrico; Morgan E Poindexter; Priya Upadhyay; Dale L Uyeminami; Arnaud Pommier; Victoria Küttner; Emilis Bružas; Laura Maiorino; Carmelita Bautista; Ellese M Carmona; Phyllis A Gimotty; Douglas T Fearon; Kenneth Chang; Scott K Lyons; Kent E Pinkerton; Lloyd C Trotman; Michael S Goldberg; Johannes T-H Yeh; Mikala Egeblad
Journal:  Science       Date:  2018-09-28       Impact factor: 47.728

5.  COP1/DET1/ETS axis regulates ERK transcriptome and sensitivity to MAPK inhibitors.

Authors:  Yuanyuan Xie; Zhen Cao; Elissa Wp Wong; Youxin Guan; Wenfu Ma; Jenny Q Zhang; Edward G Walczak; Devan Murphy; Leili Ran; Inna Sirota; Shangqian Wang; Shipra Shukla; Dong Gao; Simon Rv Knott; Kenneth Chang; Justin Leu; John Wongvipat; Cristina R Antonescu; Gregory Hannon; Ping Chi; Yu Chen
Journal:  J Clin Invest       Date:  2018-03-05       Impact factor: 14.808

6.  Pum2 Shapes the Transcriptome in Developing Axons through Retention of Target mRNAs in the Cell Body.

Authors:  José C Martínez; Lisa K Randolph; Daniel Maxim Iascone; Helena F Pernice; Franck Polleux; Ulrich Hengst
Journal:  Neuron       Date:  2019-10-09       Impact factor: 17.173

Review 7.  Guidelines for the optimal design of miRNA-based shRNAs.

Authors:  Xavier Bofill-De Ros; Shuo Gu
Journal:  Methods       Date:  2016-04-12       Impact factor: 3.608

Review 8.  CRISPR/Cas9: From Genome Engineering to Cancer Drug Discovery.

Authors:  Ji Luo
Journal:  Trends Cancer       Date:  2016-06

9.  Network Architecture Predisposes an Enzyme to Either Pharmacologic or Genetic Targeting.

Authors:  Karin J Jensen; Christian B Moyer; Kevin A Janes
Journal:  Cell Syst       Date:  2016-02-24       Impact factor: 10.304

10.  The Menu of Features that Define Primary MicroRNAs and Enable De Novo Design of MicroRNA Genes.

Authors:  Wenwen Fang; David P Bartel
Journal:  Mol Cell       Date:  2015-09-24       Impact factor: 17.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.